⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
As Enterprises Move AI Agents Into Production, OpenBox AI and Temporal Introduce Runtime Governance for Long-Running Agents
prnewswire.com
NFLX
SNOW
CHKP
DDOG
CRM
S
AMZN
GOOG
MSFT
IBM
ORCL
CSCO
INTC
NVDA
AMD
META
ADBE
PYPL
CMCSA
VZ
T
BA
GE
CAT
DIS
MCD
KO
PEP
JNJ
PG
XOM
CVX
WMT
HD
UNH
MA
V
JPM
BAC
WFC
C
GS
MS
AXP
BLK
PRU
MET
AIG
CB
MSCI
SPGI
ICE
NDAQ
AMAT
MU
ASML
KLAC
ADSK
CDNS
MRVL
QCOM
TXN
LRCX
ADI
MCHP
NXPI
ON
ALGN
BIIB
GILD
AMGN
REGN
VRTX
BMY
PFE
MRK
ABBV
LLY
JAZZ
AZN
SNY
NVS
TEVA
ACN
TMO
ISRG
DASH
UBER
LYFT
GOOGL
AAPL
TSLA
GM
F
RIVN
LCID
NIO
XPEV
PLTR
SMCI
CRWD
PANW
SNPS
MDT
EW
ABT
CI
HUM
CNC
ETSY
BKNG
EXPE
MAR
HLT
IHG
WYNN
LVS
MGM
CCL
RCL
NCLH
AAL
UAL
DAL
LUV
ALK
JBLU
Cell Isolation Market/Cell Separation Market by Product, Cell Type, Source, Technique, Application, End User, Competition, Region - Global Forecast to 2031
globenewswire.com
DHR
MRK
TMO
BDX
BIO
QGEN
NICOLAS HIERONIMUS, PDG DE L'ORÉAL, ET LOUIS THEROUX SONT LES TÊTES D'AFFICHE DE L'ÉVÉNEMENT UNLEASH À PARIS, OÙ 8 500 RESPONSABLES DES RESSOURCES HUMAINES ISSUS DE 140 PAYS SE RÉUNISSENT POUR RÉINVENTER LE TRAVAIL
prnewswire.com
SAP
BP
ADI
GOOG
META
MRK
ONON
L'ORÉAL CEO NICOLAS HIERONIMUS AND LOUIS THEROUX HEADLINE UNLEASH IN PARIS AS 8,500 HR LEADERS FROM 140 COUNTRIES CONVENE TO REINVENT WORK
prnewswire.com
SAP
BP
SONY
ACR
GOOG
META
DHX
MRK
THS
ONON
L'ORÉAL CEO NICOLAS HIERONIMUS AND LOUIS THEROUX HEADLINE UNLEASH IN PARIS AS 8,500 HR LEADERS FROM 140 COUNTRIES CONVENE TO REINVENT WORK
prnewswire.com
SAP
BP
GOOG
META
SI
AMZN
MRK
ONON
L'ORÉAL-CEO NICOLAS HIERONIMUS UND LOUIS THEROUX SIND DIE HAUPTREFERENTEN DER „UNLEASH"-VERANSTALTUNG IN PARIS, ZU DER SICH 8.500 FÜHRUNGSKRÄFTE AUS DEM PERSONALWESEN AUS 140 LÄNDERN VERSAMMELN, UM DIE ARBEIT NEU ZU GESTALTEN
prnewswire.com
SAP
BP
SONY
ACR
RYAAY
GOOG
META
SI
MRK
THRY
ONON
El consejero delegado de L'Oréal, Nicolas Hieronimus, y Louis Theroux encabezan UNLEASH en París
prnewswire.com
SAP
BP
SONY
AXP
RYAAY
GOOG
META
AD
MRK
THS
ONON
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)
businesswire.com
MRK
AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments
globenewswire.com
NVO
PFE
AZN
LLY
NVS
JNJ
MRK
SNY
Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers
globenewswire.com
AZN
MRK
NVS
PFE
BMY
SNY
AMGN
JNJ